A full-day Non-Smoking Lung Cancer Update with RSF & BTOG brought nearly 200 experts together to advance research, diagnosis & care.
Grateful to our teams and partners driving progress in NSLC understanding, treatment & best practice.
#BTOG25 #LungCancer #NSLC #Oncology
Here's the highlights reel from our 2025 Annual Conference #BTOG25
It's also available to watch on the home page of our website at www.btog.org
Congratulations to the winning posters from #BTOG25: Click to see the winners.
www.btog.org/btog-2025-po...
Agree 💪 to the patient voice
#BTOG25
Thanks to #BTOG25 for choosing our poster to present as an oral presentation (1 of only 5!) & share the incredible impact of a specialist mental health nurse working in our #lungcancer pathway. Almost all my projects fail to get funded. This team has brought me immense joy! Keep trying! #RespIsBest
Thank you for a great #BTOG25. See you next year in Edinburgh
Was really looking forward to this session and it didn't disappoint! Always find related questions the hardest to answer in clinic. Just a shame they had the graveyard slot!
@bopa.org.uk take note of the speakers, they would be great additions to annual conference agenda
#BTOG25
Well #BTOG25 that’s a wrap for 2025 from #Belfast
Thanks to @btog.bsky.social for 3 fantastic years in Belfast
It’s been an absolute pleasure to have the BTOG community over with us for the last 3 years 🙏
Here’s to next year in Edinburgh!
@drsanjaypopat.bsky.social
@tnewsomdavis.bsky.social
Four people standing next to large display letters saying "BTOG".
Patient representative, Janette, joined the TOURIST #LungCancer trial team at #BTOG25 today.
Involvement of patients like Janette in our #research ensures our #ClinicalTrials are acceptable, accessible and relevant to patients.
#PatientAndPublicInvolvement #PPI #ResearchPartners
@nihr.bsky.social
Thanks #BTOG25 for another great conference - looking forward to Edinburgh next year.
That’s it! As our 23rd annual conference closes, we’d like to thank our speakers for sharing their valuable expertise, our hosts in Belfast and all of our amazing attendees. See you again next year for #BTOG26 in Edinburgh! March 3-5 #BTOG25 #LCSM
The final session of #BTOG25 is ‘Non-medical Treatments in Cancer Patients’ chaired by Tom Newsom-Davis and Josie Roberts with
👉 Robert Thomas talking about vitamin D and sugar
👉 Chris Twelves talking about cannabinoids and cancer
👉 Robert Thomas talking about the evidence on gut health and cancer
Agree. A packed room for SCLC on the last day of a conference? Unheard of previously! Obviously all attending to listen to @annaminchom.bsky.social , @drjnaidoo.bsky.social ,& @stephenvliu.bsky.social!
@btog.bsky.social #BTOG25
Great job, team! @btog.bsky.social #BTOG25
Photo of Dr Naidoo on stage
Dr Naidoo presenting conclusions
Compares future to various movies
Professor @drjnaidoo.bsky.social welcomed to the #BTOG25 stage as a Lung Cancer Legend & doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards & future treatments. #LCSM
Excellent conference at #BTOG25 My pleasure to present our data on SCLC, Mesothelioma and resectable NSCLC from The Royal Marsden
But beware of the real world…. Potentially less fit patients as compared to the trial population #BTOG25
@annaminchom.bsky.social on newer small cell therapeutic strategies and management of CRS and ICANS as specific TRAEs With thought around timings of dose delivery and education of AOS teams and patients, safely deliverable within the NHS
#BTOG25
SCLC was indeed the star at #BTOG25. Looking forward to the benefit (and challenges) of novel therapeutic strategies.
Translational studies to aid patient selection will now be more needed than ever.
Although @stephenvliu.bsky.social is hard to follow, we’ve just had an absolute tour de force by @drjnaidoo.bsky.social at #BTOG25 on #SCLC
➡️ Discusses NRG005 and the better outcomes for patients reviving twice daily radiotherapy.
➡️ Continued evidence of a benefit from PCI in LS-SCLC
No one with #LungCancer should wait more than 14 days for genomic test results.
Yet in some UK regions, patients are facing delays of several weeks.
This is unacceptable. ⚠️
Read our new report and help us put this right ow.ly/lxak50V9wEs
#BTOG25
Congratulations to Lauren Dixon and the rest of the NLCA team at #BTOG25. Poster prize winners for work on national patterns of SACT use in lung cancer
With the successful role out of the TLHC programme, we now have a growing cohort of stage 1 SCLC patients. Hopefully this will become even more common, and work needed to understand optimal patient management @drjnaidoo.bsky.social #BTOG25
Small cell in never smokers. On the rise for unknow reasons and a different biology. Having recently encountered my first patient who’s a never smoker(and no alcohol or recreational drugs), with extensive stage disease this insight is fascinating @stephenvliu.bsky.social #BTOG25
@drjnaidoo.bsky.social on the limited stage small cell space and the excitement around CCRT-Durvalumab. EAMS currently open in England… #BTOG25
@stephenvliu.bsky.social on excitement in the Small Cell arena. PDL1/PD1 inhibition a practice changer, but so many potential game changers on the horizon from BITES To ADC, it’s exciting to see new drugs for an area of unmet need #BTOG25
The next session is titled, ‘Small Cell Lung Cancer: A New Awakening’ and is chaired by Star Wars fans Shobhit Baijal and Gerard Walls with Stephen Liu, Jarushka Naidoo and Anna Minchom speaking. #BTOG25
The Force is strong with these ones …
Historic moment at #BTOG25 at last evening’s dinner where Professor @drsanjaypopat.bsky.social finished his 13 year tenure as BTOG Chair & heralded the great progress. The reigns (& clapper) hv now been handed to Dr @tnewsomdavis.bsky.social.
Patient advocates grateful for progress & keen for more
At #BTOG25 & I tringied by Matt’s comment on the fact that GP practices who request more chest X-rays have less stage III/IV #lungcaner disease? Read more here! www.respiratoryfutures.org.uk/features/dia...
